• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎患者亚急性甲状腺炎。

Subacute Thyroiditis in COVID-19 Patients.

机构信息

Faculty of Medicine, Department of ENT, 209002İstanbul Yeni Yüzyıl University, İstanbul, Turkey.

Department of Internal Medicine, 209002Bahat Hosphital, Sultangazi, İstanbul, Turkey.

出版信息

Ear Nose Throat J. 2022 Sep;101(8):501-505. doi: 10.1177/01455613211012114. Epub 2021 May 11.

DOI:10.1177/01455613211012114
PMID:33974811
Abstract

OBJECTIVE

As a result of the COVID-19 pandemic that occurred in the last year, it has been revealed that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) does not only cause viral respiratory tract infection but can also affect many organs in the short or long term. In our study, we aimed to reveal that COVID-19 infection affects the endocrine system and triggers subacute thyroiditis (SAT) in the acute period.

MATERIAL AND METHOD

In our retrospective study, the ear-nose-throat examination, internal diseases consultation (investigation of COVID-19 symptoms and polymerase chain reaction [PCR] test), routine blood tests, T3, T4, thyroid-stimulating hormone, antithyroglobulin (anti-TG), antithyroid peroxidase (anti-TPO), thyroid scintigraphy, and thyroid ultrasonography results of 5 patients who applied to the otorhinolaryngology clinic due to complaints of neck pain and odynophagia between April 2020 and February 2021 were examined.

FINDINGS

All 5 patients were female patients (30.4 years) with odynophagia and pain in the front lower region of the neck. These patients had no previous history of thyroiditis. COVID-19 PCR tests of the patients diagnosed with SAT were positive, and there were no typical COVID-19 signs and symptoms except odynophagia and neck pain.

RESULT

It comes in view that SARS-COV-2 affects thyroid functions and causes SAT and the main symptoms in patients are pain in the neck and odynophagia.

摘要

目的

由于去年发生的 COVID-19 大流行,已经表明严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)不仅会引起病毒性呼吸道感染,而且还会在短期或长期内影响许多器官。在我们的研究中,我们旨在揭示 COVID-19 感染会影响内分泌系统并在急性期引发亚急性甲状腺炎(SAT)。

材料和方法

在我们的回顾性研究中,对因颈痛和咽痛而于 2020 年 4 月至 2021 年 2 月间就诊耳鼻喉科的 5 例患者进行了耳鼻喉检查、内科咨询(调查 COVID-19 症状和聚合酶链反应(PCR)检测)、常规血液检查、T3、T4、促甲状腺激素、抗甲状腺球蛋白(抗-TG)、抗甲状腺过氧化物酶(抗-TPO)、甲状腺闪烁显像和甲状腺超声检查。

结果

所有 5 例患者均为女性(30.4 岁),有咽痛和颈前下部疼痛。这些患者均无甲状腺炎既往史。经 SAT 诊断的患者的 COVID-19 PCR 检测呈阳性,除咽痛和颈痛外,无典型 COVID-19 体征和症状。

结果

SARS-COV-2 会影响甲状腺功能并导致 SAT,患者的主要症状为颈部疼痛和咽痛。

相似文献

1
Subacute Thyroiditis in COVID-19 Patients.新型冠状病毒肺炎患者亚急性甲状腺炎。
Ear Nose Throat J. 2022 Sep;101(8):501-505. doi: 10.1177/01455613211012114. Epub 2021 May 11.
2
Subacute Thyroiditis After Sars-COV-2 Infection.感染 SARS-CoV-2 后发生亚急性甲状腺炎。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa276.
3
HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.接种 SARS-CoV-2 疫苗后发生亚急性甲状腺炎和格雷夫斯病的患者的 HLA 分型:病例报告。
BMC Endocr Disord. 2023 Mar 7;23(1):54. doi: 10.1186/s12902-023-01287-5.
4
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.亚急性甲状腺炎是 SARS-CoV-2 感染的被低估表现吗?一项病例系列研究的启示。
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa537.
5
Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review.SARS-CoV-2 相关亚急性甲状腺炎患者的临床、生化特征和功能结局:综述。
Endocrine. 2023 Mar;79(3):448-454. doi: 10.1007/s12020-022-03247-w. Epub 2022 Nov 17.
6
Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study.SARS-CoV-2 时代的亚急性甲状腺炎:一项多中心前瞻性研究。
Eur Thyroid J. 2024 Jun 24;13(3). doi: 10.1530/ETJ-24-0083. Print 2024 Jun 1.
7
Subacute thyroiditis during the COVID-19 pandemic: a prospective study.COVID-19 大流行期间的亚急性甲状腺炎:一项前瞻性研究。
J Endocrinol Invest. 2022 Apr;45(4):865-874. doi: 10.1007/s40618-021-01718-x. Epub 2022 Jan 13.
8
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review.COVID-19 继发亚急性甲状腺炎的危险因素、治疗方法和结局:系统评价。
Intern Med J. 2022 Apr;52(4):522-529. doi: 10.1111/imj.15432.
9
Subacute thyroiditis after COVID-19.COVID-19 后亚急性甲状腺炎。
Tidsskr Nor Laegeforen. 2021 Jun 28;141(10). doi: 10.4045/tidsskr.21.0169. Print 2021 Jun 29.
10
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.SARS-CoV-2 感染患者的亚急性甲状腺炎:与 COVID-19 大流行相关的内分泌并发症。
Hormones (Athens). 2021 Mar;20(1):219-221. doi: 10.1007/s42000-020-00230-w. Epub 2020 Jul 16.

引用本文的文献

1
Euthyroid Sick Syndrome as an Index of Prognosis in Severe COVID-19 Disease.正常甲状腺病态综合征作为重症 COVID-19 疾病预后的一个指标
Medicina (Kaunas). 2025 Jul 29;61(8):1372. doi: 10.3390/medicina61081372.
2
THYROID FUNCTION IN PATIENTS WITH COVID-19: A RETROSPECTIVE STUDY.新型冠状病毒肺炎患者的甲状腺功能:一项回顾性研究。
Acta Clin Croat. 2023 Dec;62(4):623-626. doi: 10.20471/acc.2023.62.04.6.
3
Long-Term Impacts of COVID-19 on Thyroid Health: Insights From Clinical Studies.新冠病毒病对甲状腺健康的长期影响:来自临床研究的见解
Cureus. 2024 Oct 14;16(10):e71469. doi: 10.7759/cureus.71469. eCollection 2024 Oct.
4
Subacute thyroiditis after receiving the COVID-19 vaccine.接种新冠疫苗后发生亚急性甲状腺炎。
Respir Med Case Rep. 2024 Aug 30;51:102096. doi: 10.1016/j.rmcr.2024.102096. eCollection 2024.
5
Subacute Thyroiditis in Active COVID-19 Infection: A Report of Two Cases With a Systematic Review of the Literature.新型冠状病毒肺炎(COVID-19)感染活动期的亚急性甲状腺炎:两例报告及文献系统综述
Cureus. 2024 Jan 20;16(1):e52611. doi: 10.7759/cureus.52611. eCollection 2024 Jan.
6
Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic.亚急性甲状腺炎的临床情况:希腊在新冠疫情期间对226例病例的实际研究
J Clin Med. 2023 Nov 18;12(22):7171. doi: 10.3390/jcm12227171.
7
New-onset and relapsed Graves' disease following COVID-19 vaccination: a comprehensive review of reported cases.接种 COVID-19 疫苗后新发和复发性 Graves 病:已报告病例的综合回顾。
Eur J Med Res. 2023 Jul 13;28(1):232. doi: 10.1186/s40001-023-01210-7.
8
Subacute thyroiditis following COVID-19: A systematic review.COVID-19 后亚急性甲状腺炎:系统评价。
Front Endocrinol (Lausanne). 2023 Apr 5;14:1126637. doi: 10.3389/fendo.2023.1126637. eCollection 2023.
9
The Influence of SARS-CoV-2 Infection on the Thyroid Gland.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染对甲状腺的影响。
Biomedicines. 2023 Feb 18;11(2):614. doi: 10.3390/biomedicines11020614.
10
Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review.SARS-CoV-2 相关亚急性甲状腺炎患者的临床、生化特征和功能结局:综述。
Endocrine. 2023 Mar;79(3):448-454. doi: 10.1007/s12020-022-03247-w. Epub 2022 Nov 17.